Live biotech updates | Page 3

Live biotech news coverage of developments with the latest updates. Stay on top of latest biotech news stories and find out what just happened, what is going on with biotech. The latest real-time news updates and headlines on biotech
Victoria’s Medtech Manufacturing Capability Programme opens
FDA Clearance of Plasma Collection Technology
CAR-T therapy modifications provides new promise for cancer immunotherapies
Recognition for Vetter in CMO Leadership Awards
Chimeric Therapeutics announces final results from Phase 1 trial of CORE NK Platform
International Women’s Day: AusBiotech ‘moving dial’ on gender equity
Antisense Therapeutics confirms ATL1102 poster presentation
New expedited regulatory pathway proposed for novel biologicals
Forbes Ranks CSL Among America’s Best Employers
Approval for Neuren Pharmaceuticals’ Phase 2 trial in Angelman syndrome
Patrys selects stable cell line for production of PAT-DX3
Lucy Turnbull AO rejoins board of Immutep
AusBiotech highlights clarity and transparency is key in recent submissions
Kazia Therapeutics to be ‘transformed’ by pipeline progress
New award recognises industry’s role in clinical trials
Arovella Therapeutics closes over-subscribed share purchase plan
Important support programme oversubscribed
Amplia says new report ‘paves way’ for its phase 2 trial
Engage early on reimbursement and regulation strategies
Vaccine developer Sementis appoints chief operating officer
New Prostheses List pathways proposed
New chair for Agricultural Biotechnology Council of Australia
New glaucoma test set to roll out
Scientists make nonalcoholic beer taste like regular beer
CSL campaign challenging stereotypes about people working in science
Tessara Therapeutics announces key senior appointments
Senate Inquiry into sovereign manufacturing report released
AusBiotech greets patent box legislation
Medlab Clinical updates on progress towards phase 3 trial
NeuroScientific Biopharmaceuticals reports outcomes of pre-clinical studies
Applications for Bridge Programme 2022 open
Cytiva announces winner of Australia-NZ BioChallenge
Changes proposed to TGA fees and charges
New trial underway of Pharmaxis’ first-in-class LOX inhibitor
Exopharm announces new agreement with Astellas Institute for Regenerative Medicine
Certainty offered for RDTI clinical trial activities
First patient dosed in Telix ‘ProstACT’ therapeutic program
Keynote announced for NSW Women in Life Sciences Luncheon
Wageningen University & Research and VectorY to jointly develop novel production technologies for safer and more affordable gene
Technovalia announces interim safety results from vaccine phase 1 trial
Significant capital raise for emerging Australian company
Global biomanufacturing report seeks Australian voice
BiomeBank appoints new chair to accelerate commercialisation strategy
Pharmaxis welcomes government research grants for new study collaborations
Patients dosed in Dimerix’s DMX-200 Covid late-stage study in India
Recharged with resolutions for 2022
CSL Publishes Vifor Offer Prospectus
A “big push” to lift people out of poverty